Most Active Stories
- Prof. Nancy Prideaux, University of Texas Austin – Logistics of Black Friday
- Dr. Susan Fiske, Princeton University - Baseball and Schadenfreude
- F-35 To Be Housed At Vermont Air Guard Base
- Dr. David Hsu, University of Michigan – The Pain of Social Rejection
- White House Cites Pre-Existing Condition Case From Its Own Ranks
New York News
Sun June 16, 2013
Researchers Analyze Drug Campaigns’ Efforts to Sell Disease
Dartmouth Institute researchers Doctors Lisa Schwartz and Steven Woloshin have published a paper in the Journal of the American Medical Association (JAMA) analyzing how the Low Testosterone advertisements so prevalent on television are a perfect template for how drug companies manufacture and sell disease. WAMC’s North Country Bureau Chief Pat Bradley spoke recently with “Low T: How to Sell Disease” co-author Steven Woloshin.
The ads are all over television and the internet.
This ad from isitlowt-dot-com is a perfect example, according to two Dartmouth Institute for Health Policy & Clinical Practice researchers, of how drug companies are creating “disease awareness” campaigns. “Low T: How to Sell Disease” co-author Steven Woloshin says obstensibly the ads are an effort to teach people and medical professionals about a problem and potential treatment.
The Dartmouth Institute and the authors of “Low T How to Sell Disease” will host an international conference at Dartmouth in September on preventing overdiagnosis.